Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship

BOSTON, July 15 /PRNewswire/ -- Bayer HealthCare announced today the recipients of the 2009 World Federation of Hemophilia's International Hemophilia Nursing Fellowship. This Bayer-supported initiative provides hemophilia education and training to nurses in developing countries - areas where hemop...

Bayer HealthCare Awards $2.5 Million to Advance Hemophilia Research and Improve Patient Care

BOSTON, July 14 /PRNewswire/ -- Bayer HealthCare announced today that it awarded 20 individuals from nine countries funding totaling nearly $2.5 million through the Bayer Hemophilia Awards Program (BHAP). As the largest program of its kind in hemophilia, BHAP supports innovative research and educa...

Bayer HealthCare Launches Hemophilia Self-Infusion Training Program

WAYNE, N.J., July 9 /PRNewswire/ -- Today, Bayer HealthCare Pharmaceuticals launched the BayCuff(TM) self-infusion training program, an educational initiative designed to make infusion of recombinant factor VIII easier for both patients with hemophilia A and for their caregivers. The centerpiece ...

Strides Made in Hemophilia Research

Successful blood-clotting in lab could pave way for human trials, researchers say TUESDAY, June 16 (HealthDay News) -- Researchers studying the bleeding disease hemophilia in mice have increased the rodents' ability to produce a crucial blood-clotting protein, a new study says. Their s...

New Partnerships Added to World Federation of Hemophilia Twinning Program

Wyeth and Advocacy Community Mark Continued Commitment to Patient Care on World Hemophilia Day COLLEGEVILLE, Pa., April 17 /PRNewswire/ -- In honor of the twentieth Anniversary of World Hemophilia Day, Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), together with the World Federat...

CSL Behring Marks World Hemophilia Day with $2M Coagulation Factor Donation to World Federation of Hemophilia

Three-year commitment will aid WFH's Global Alliance for Progress program to improve healthcare in the developing world King of Prussia, PA, and Montreal, Canada (PRWEB) April 17, 2009 -- In recognition of the World Federation of Hemophilia's (WFH) progress in improvi...

Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia

BERKELEY, Calif., April 17 /PRNewswire/ -- In recognition of the 20th anniversary of World Hemophilia Day, Bayer HealthCare reaffirmed its commitment to the global hemophilia community by pledging euro 250,000 to the World Federation of Hemophilia (WFH). To mark this milestone, Bayer employees aro...

National Hemophilia Foundation's (NHF) CEO Featured in Black Enterprise Magazine

NEW YORK, Nov. 12 /PRNewswire/ -- Val Bias, Chief Executive Officer of the National Hemophilia Foundation is featured in the November 2008 issue of Black Enterprise magazine in the "On the Move" section of the Powerplay Department. The department highlights African-American men and women who h...

FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors

First Recombinant Room Temperature Stable Treatment for Hemophilia With Inhibitors Offers More Flexibility and Convenience to Patients PRINCETON, N.J., May 13 /PRNewswire-FirstCall/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved NovoSeven(R) RT ...

National Hemophilia Foundation Asks America to Make a Difference With National Fundraising Initiative

National Walk to help raise money for crucial research, advocacy and education NEW YORK, April 17 /PRNewswire/ -- The National Hemophilia Foundation (NHF) today announced its first-ever national fundraising and awareness campaign -- the Hemophilia Walk, presente...

Hemophilia in Medical Technology

Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B

IB1001, an Intravenous Recombinant Factor IX (rFIX) Product for the Treatment of Hemophilia B LAGUNA NIGUEL, Calif., Feb. 12 /PRNewswire/ -- Inspiration Biopharmaceuticals, Inc., today announced the initiation of a Phase 1 clinical trial of IB1001, an intravenous (IV) recombinant Factor IX (r...

FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A

Pivotal Data Show Prophylaxis Treatment with Kogenate FS Reduces the Risk of Joint Damage and Frequent Bleeds in Children with No Pre-Existing Joint Damage BERKELEY, Calif., Oct. 10 /PRNewswire/ -- Bayer HealthCare LLC announced today that the U.S. Food and Drug Administration (FDA) has appr...

Baxter Announces Recombinant Factor IX Development Program For Hemophilia B

DEERFIELD, Ill., Jan. 7 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: BAX ) announced today that it has initiated pre-clinical programs to develop recombinant Factor IX proteins to treat hemophilia B. Baxter will develop both an unmodified recombinant Factor IX therapy for treatm...

Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B

LAGUNA NIGUEL, Calif., Nov. 13 /PRNewswire/ -- Inspiration Biopharmaceuticals announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin clinical trials with IB1001, an intravenous recombinant Factor IX (rFIX) produ...

Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia

SOUTH SAN FRANCISCO, Calif., May 6 /PRNewswire/ -- Catalyst Biosciences, Inc., a pioneer in the discovery and development of engineered proteases known as Alterase(TM) therapeutics, announced that it has selected CB 813, an improved, second-generation variant of human coagulation factor VIIa, ...

Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients

...ing global protein therapy market, which is forecast to reach US $87 billion by 2010. Other potential areas include multiple sclerosis (interferon-B), hemophilia (Factor VIII), pediatric growth hormone deficiency (human growth hormone) and diabetes (insulin). Founded in 2000, Medgenics is a US-incorporate...

KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research

...ostat would turn off automatically in the body. In addition to helping soldiers, the Hemostat has potential for use in civilian surgery and cases of hemophilia and hemorrhagic stroke. Phillips is also working on ways to add a stem cell homing factor gene to the Hemostat system that would cause stem cells to b...

Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines

...re not known at this time. Diabetes and high blood sugar have occurred in patients taking protease inhibitors, such as KALETRA. Some patients with hemophilia have increased bleeding with protease inhibitors. The effects of KALETRA on pregnant women or their unborn babies are not known. Mothers taking KALE...

Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds

...nditions such as cancers, sickle cell disease and thalassemia, diabetes, asthma, HIV/AIDS, pediatric obesity, nutritional deficiencies, birth defects, hemophilia and cystic fibrosis. About Quest Diagnostics Quest Diagnostics is the leading provider of diagnostic testing, information and services that patien...

Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress

...e(R) line of products and more than two decades of hemophilia A research, collaboration and community building at the 2008 World Federation of hemophilia (WFH) World Congress in Istanbul, Turkey. More tha...ivery of safe, effective treatment for people with hemophilia A. Since then, Bayer's Kogenate(R) line of product...

Hemophilia in Medical Products

Air-Stirrup® Ankle Brace

Description:...rt of an Ankle Sprain Care Kit™. The Pediatric Ankle Brace is designed for children 2 to 6 years of age and is ideal for ankle stabilization in hemophilia patients. Extra long straps are available contact Customer Service for more information....
Company:Aircast

Pediatric Knee/Elbow Cryo/Cuff™

Features:...sion for patient comfort Controlled cold eliminates the risk of tissue damage Detachable cooler allows for uninterrupted treatment Treatment for hemophilia hemorrhage Sizes for both pediatric and adult patients ...
Company:Aircast

Pediatric Ankle Cryo/Cuff™

Features:...sion for patient comfort Controlled cold eliminates the risk of tissue damage Detachable cooler allows for uninterrupted treatment Treatment for hemophilia hemorrhage Sizes for both pediatric and adult patients ...
Company:Aircast

Hemophilia in Medical Definition

Hematopathology

...lobinuria ) • Aplastic anemia : ( Acquired pure red cell aplasia , Fanconi anemia ) • Hemochromatosis Coagulation / platelets DIC • hemophilia ( A , B , C ) • Von Willebrand disease • Purpura ( Henoch-Schönlein , ITP , TTP ) other Methemoglobinemia - Langerhans cell histio...

Pathology

...lobinuria ) • Aplastic anemia : ( Acquired pure red cell aplasia , Fanconi anemia ) • Hemochromatosis Coagulation / platelets DIC • hemophilia ( A , B , C ) • Von Willebrand disease • Purpura ( Henoch-Schönlein , ITP , TTP ) other Methemoglobinemia - Langerhans cell histio...

Hemophilia in Medical Dictionary

Hemophilia

User-edited article about haemophilia , a hereditary genetic illness that impairs the body's ability to control bleeding. Deficiency in coagulation factor VIII is the most common cause of hemophilia . ... Hemophilia is quite rare, with only about 1 instance in every 10,000 births ...

Hemophilia A

... factor VIII. This protein serves as a ... hemophilia is a rare bleeding disorder in which your blood doesn't clot normally. ... If you have hemophilia , you may bleed for a longer time than others after ... There are two types of hemophilia , A and B (Christmas Disease) ... Patients with ...

Hemophilia B

... hemophilia (A/VIII, B /IX, C/XI) • Von Willebrand disea... Haemophilia B , factor IX is deficient. ... hemophilia (A/VIII, B /IX, C/XI) • Von Willebrand disease • Hypoprothrombinemia/II · XIII ... hemophilia B - Overview, ...

Factor VIII assay

...r VIII (one of the ... Factor VIII assay . hemophilia A. Test Reference. Rare Diseases ... More on t... Activity Assay , Plasma. Useful For. Diagnosing hemophilia A ... Factor VIII Activity Assay . hemophilia A. Specimen Required ... ... activation of fa...

Factor II deficiency

...hat runs in families (inherited) ... commonly, factor II deficiency is ... MedlinePlus Encyclopedia: Factor II deficiency ... National hemophilia Foundation: Factor II Deficiency ... Factor II Deficiency . Hypoprothrombinemia. See How ... ... form of Factor II deficiency ,[1]...

Blood disorders

... Facts ... ... white cells, platelets, plasma, and enzymes that control what the blood does. ... Information on the disorder from the National hemophilia Foundation. ... blood disorder synonyms, blood disorder antonyms. Information about blood disorder in the free ... alkalemia - a bloo...

Bleeding disorders

...isorders : Financial and Insurance Issues(National hemophilia Foundation) ... Bleeding and Clotting Disorders...pes of bleeding disorders . World Federation of hemophilia ... (Redirected from Bleeding disorders ) J...lot properly. ... Bleeding disorders such as hemophilia and von Willebrand ... ...

Bleeding disorder

...rs , the. platelets or clotting factors do ... hemophilia is an inherited bleeding disorder . ... Bleedi...isorders : Financial and Insurance Issues(National hemophilia Foundation) ... Bleeding disorders are a g... disorders . Provided by the U.S. Centers for ... hemophilia is an inherited bleeding disorder that affects...

Hemophilia in Biological News

UT scientist receives hemophilia research award

Keri Smith, Ph.D., an assistant professor of pathology and laboratory medicine at The University of Texas Health Science Center at Houston, has received a Career Development Award from the National Hemophilia Foundation. The award will support Smith's research into the development of a therapy...

Ancient DNA helps UF researchers unearth potential hemophilia therapy

A cut can be life-threatening for people with hemophilia, whose bodies don't produce enough of a protein that prevents prolonged bleeding. Now University of Florida researchers may be one step closer to finding a safe way to spur production of this missing protein in patients with the most common...

Gene therapy advance treats hemophilia in mouse models

Vector improved in two ways creates a sustained, partial correction to bleeding problems in mice A virus that typically infects insects could help with the development of gene therapy treatment for Hemophilia A, a condition in which even a bump on the knee can cause serious internal bleeding in ...

Embryonic Stem Cells Treated With Growth Factor Reverse Hemophilia In Mice: UNC Researchers

University of North Carolina at Chapel Hill researchers have made a discovery that may have implications for the treatment of liver-based genetic defects such as hemophilia A and B in humans. Mouse embryonic stem cells treated in culture with a growth factor and then injected into the liver reve...

NIH stimulus funding supports Emory biomedical scientists

... of dietary phosphate on a mouse model of prostate cancer. Understanding hemophilia and other clotting disorders: If your blood has trouble clotting, you might... Understanding blood-clotting proteins can improve treatments for inherited hemophilia and cardiovascular disease. This study looks at one particular clotting pro...

Mapping a clan of mobile selfish genes

... DNA into pieces. Geneticists have already identified over 40 Alu elements that interrupt genes and cause human diseases, including neurofibromatosis, hemophilia and breast cancer, Devine says. Bennett and Devine tested Alu elements by putting each of 89 family representatives on a small circle of DNA next t...

UF researchers develop improved gene therapy agent

...lacing a different tyrosine in each one and inserting in them the gene that triggers production of the blood-clotting protein Factor IX. Patients with hemophilia B, a common form of the disease, do not naturally produce this protein. In tissue samples and in mice, all the new vectors worked better than a co...

NHLBI issues first US von Willebrand Disease clinical practice guidelines

...risks, especially during surgery, following an injury, or during childbirth. VWD affects 1 out of every 100 to 1,000 people - both males and females. hemophilia mainly affects males. These are the first guidelines on von Willebrand Disease published in the United States and we are pleased to offer clini...

A transplant in time

... In hemophilia, a mutated gene prevents the production of a critical blood-clotting protein. Treatments for hemophilia and other such genetic diseases, when they exist, may consist of risky blood transfusions or expensive enzyme replacement therapy. But what if the bod...

Polymer aids in blood clotting, pointing way to new treatment

...lving uncontrollable bleeding. Such scenarios, Morrissey said, could include treatment for wounds sustained on battlefields or in accidents, or for hemophilia and other diseases with coagulation deficits. "The big picture is that we've found a new function for an ancient molecule," he said. "Polyphosphate...

Hemophilia in Biological Technology

Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting

LAGUNA NIGUEL, Calif., July 14 /PRNewswire/ -- Inspiration Biopharmaceuticals today announced the presentation of positive preclinical safety, toxicology and preliminary pharmacokinetic data on its lead product, IB1001, a novel recombinant Factor IX product to treat patients with he...

Diplomat Specialty Pharmacy Expands National Hemophilia & IVIG Program

SWARTZ CREEK, Mich., Feb. 4 /PRNewswire/ -- Diplomat Specialty Pharmacy is pleased to announce two new "Navigator" initiatives (disease management programs). As of January 2009, DSP launched both a Hemophilia and IVIG Navigator Program. In addition, Scott Reed has joined Diplomat as National...

Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement

GAITHERSBURG, Md. and ATLANTA, Feb 4 /PRNewswire/ -- Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, and Expression Therapeutics, a biotechnology company specializing in factor VIII-based therapeutics, today an...

New Recombinant XYNTHA Now Available for Patients with Hemophilia A

COLLEGEVILLE, Pa., Sept. 8 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), announced today that product shipments have begun for XYNTHA(TM) Antihemophilic Factor (Recombinant), Plasma/Albumin-Free, a new recombinant factor VIII product for both the control and prevent...

CSL Behring's Innovative HeliTrax(SM) System Helps Physicians Manage Hemophilia A Patients

Wireless Device Provides Comprehensive Clinical Picture, Improves Patient-Physician Communications KING OF PRUSSIA, Pa., Aug. 25 /PRNewswire/ -- Hemophilia A patients who use Helixate(R) FS, Antihemophilic Factor (Recombinant), and their treatment providers are now tracking treatment progres...

AMT Starts Collaboration With St. Jude Children's Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy

AMSTERDAM, The Netherlands, July 15 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced the start of a collaboration with St. Jude Children's Research Hospital in Memphis, Tennessee, USA, on the development of...

AMT Makes Important Advance in the Development of its Gene Therapy for Hemophilia B -Company Accesses Technology to Prevent Immune Response

AMSTERDAM, The Netherlands, June 10 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a license from 'TIGET' San Raffaele Telethon Institute For Gene Therapy, Italy, to use their micro-RNA t...

Transplanted cells may hold the key to curing hemophilia A, Einstein scientists report

Scientists at the Albert Einstein College of Medicine of Yeshiva University have shown for the first time that transplanted cells can cure hemophilia A (the most common form of the disease) in an animal model. Their study appears online February 14 in the Journal of Clinical Investigation. Hemo...

VIRxSYS Publishes New Study on RNA Therapy

... New RNA therapy reversed hemophilia in mice GAITHERSBURG, Md., April 6 /PRNewswir...these, Factor VIII, they showed they could correct hemophilia A in mice. The researchers believe their technolog..., which makes the protein missing in patients with hemophilia A. We instructed the liver to make more apoA-I pro...

Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development

..., which will not only help us add capabilities to our protease drug discovery platform, but also promote our drug development efforts in areas such as hemophilia and related clotting disorders, and age-related macular degeneration and other complement-mediated diseases." Professor Robert J. Fletterick, Ph....

Hemophilia in Biological Definition

Blood

...rculation blockage can also create many medical conditions from ischemia in the short term to tissue necrosis and gangrene in the long term. hemophilia is a genetic illness that causes dysfunction in one of the blood's clotting mechanisms . This can allow otherwise inconsequential wounds to be life-...

Gene therapy

...e logical step of trying to introduce genes straight into human cells, focusing on diseases caused by single-gene defects, such as cystic fibrosis , hemophilia , muscular dystrophy and sickle cell anemia . However, this has been much harder than modifying simple bacteria, primarily because of the problems ...

Human

... are hemizygous for the blood-clotting gene since there is no gene on the Y chromosome to control blood clotting. As a result, men will suffer from hemophilia more often than women. Intelligence Main article: human intelligence ; see below: Human#Consciousness Leonardo da Vinci 's ...

X chromosome

...romosome. Diseases well known for their X-linked recessive inheritance are hemophilia (types A and B), and color blindness . There are few examples of X-linked... Coffin-Lowry syndrome Fabry disease fragile X syndrome hemophilia incontinentia pigmenti Lesch-Nyhan syndrome Menkes synd...